Citations for
1APOL1, UBD
UBD modifies APOL1-induced kidney disease risk.
Zhang JY, Wang M, Tian L, Genovese G, Yan P, Wilson JG, Thadhani R, Mottl AK, Appel GB, Bick AG, Sampson MG, Alper SL, Friedman DJ, Pollak MR.
Proc Natl Acad Sci U S A 115(13):3446-3451. doi: 10.1073/pnas.1716113115. Epub 2018 Mar 12. 2018
2ISG15, UBD
Newly translated proteins are substrates for ubiquitin, ISG15, and FAT10.
Spinnenhirn V, Bitzer A, Aichem A, Groettrup M.
FEBS Lett 591(1):186-195. doi: 10.1002/1873-3468.12512. Epub 2016 Dec 20. 2017
3EEF1A1, UBD
The ubiquitin-like protein FAT10 stabilizes eEF1A1 expression to promote tumor proliferation in a complex manner.
Liu X, Chen L, Ge J, Yan C, Huang Z, Hu J, Wen C, Li M, Huang D, Qiu Y, Hao H, Yuan R, Lei J, Yu X, Shao J.
Cancer Res ancer Res. 2016 Jun 16. pii: canres.3118.2015. [Epub ahead of print] 2016
4DDX58, UBD
Ubiquitin-like modifier FAT10 attenuates RIG-I mediated antiviral signaling by segregating activated RIG-I from its signaling platform.
Nguyen NT, Now H, Kim WJ, Kim N, Yoo JY.
Sci Rep 6:23377. doi: 10.1038/srep23377. 2016
5UBA6, UBD, UBE2Z
Structure of UBE2Z Enzyme Provides Functional Insight into Specificity in the FAT10 Protein Conjugation Machinery.
Schelpe J, Monté D, Dewitte F, Sixma TK, Rucktooa P.
J Biol Chem 291(2):630-9. doi: 10.1074/jbc.M115.671545. Epub 2015 Nov 10. 2016
6LMO2, UBA6, UBD, USE1
LMO2 blocks the UBA6-USE1 interaction and downstream FAT10ylation by targeting the ubiquitin fold domain of UBA6.
Wu C, Liu Y, Gu X, Zhu T, Yang S, Sun W.
Biochem Biophys Res Commun 478(3):1442-8. doi: 10.1016/j.bbrc.2016.08.143. Epub 2016 Aug 26. 2016
7UBA1, UBD
Conjugation of the ubiquitin activating enzyme UBE1 with the ubiquitin-like modifier FAT10 targets it for proteasomal degradation.
Bialas J, Groettrup M, Aichem A.
PLoS One 10(3):e0120329. doi: 10.1371/journal.pone.0120329. eCollection 2015. 2015
8UBD
The Ubiquitin-like Modifier FAT10 Is Selectively Expressed in Medullary Thymic Epithelial Cells and Modifies T Cell Selection.
Buerger S, Herrmann VL, Mundt S, Trautwein N, Groettrup M, Basler M.
J Immunol 195(9):4106-16. doi: 10.4049/jimmunol.1500592. Epub 2015 Sep 23. 2015
9STAT3, UBD
NFκB and STAT3 synergistically activate the expression of FAT10, a gene counteracting the tumor suppressor p53.
Choi Y, Kim JK, Yoo JY.
Mol Oncol 8(3):642-55. doi: 10.1016/j.molonc.2014.01.007. Epub 2014 Jan 24. 2014
10UBD
Increased FAT10 expression is related to poor prognosis in pancreatic ductal adenocarcinoma.
Sun GH, Liu YD, Yu G, Li N, Sun X, Yang J.
Tumour Biol 35(6):5167-71. doi: 10.1007/s13277-014-1670-1. Epub 2014 Feb 4. 2014
11UBD
FAT10 protects cardiac myocytes against apoptosis.
Peng X, Shao J, Shen Y, Zhou Y, Cao Q, Hu J, He W, Yu X, Liu X, Marian AJ, Hong K.
J Mol Cell Cardiol 59:1-10. doi: 10.1016/j.yjmcc.2013.01.018. Epub 2013 Feb 13. 2013
12UBD
Structure of a compact conformation of linear diubiquitin.
Rohaim A, Kawasaki M, Kato R, Dikic I, Wakatsuki S.
Acta Crystallogr D Biol Crystallogr 68(Pt 2):102-8. Epub 2012 Jan 13. 2012
13UBD
FAT10 is a proteasomal degradation signal that is itself regulated by ubiquitination.
Buchsbaum S, Bercovich B, Ciechanover A.
Mol Biol Cell 23(1):225-32. Epub 2011 Nov 9. 2012
14NUB1, PSMD4, UBD
FAT10 and NUB1L bind to the VWA domain of Rpn10 and Rpn1 to enable proteasome-mediated proteolysis.
Rani N, Aichem A, Schmidtke G, Kreft SG, Groettrup M.
Nat Commun 3:749. doi: 10.1038/ncomms1752. 2012
15AIPL1, NUB1, UBD
The inherited blindness protein AIPL1 regulates the ubiquitin-like FAT10 pathway.
Bett JS, Kanuga N, Richet E, Schmidtke G, Groettrup M, Cheetham ME, van der Spuy J.
PLoS One 7(2):e30866. doi: 10.1371/journal.pone.0030866. Epub 2012 Feb 7. 2012
16UBA6, UBD
Mechanistic studies on activation of ubiquitin and di-ubiquitin-like protein, FAT10, by ubiquitin-like modifier activating enzyme 6, Uba6.
Gavin JM, Chen JJ, Liao H, Rollins N, Yang X, Xu Q, Ma J, Loke HK, Lingaraj T, Brownell JE, Mallender WD, Gould AE, Amidon BS, Dick LR.
J Biol Chem 287(19):15512-22. doi: 10.1074/jbc.M111.336198. Epub 2012 Mar 15. 2012
17LRRFIP2, TLR4, TOR1AIP2, UBD
Modification of the inflammatory mediator LRRFIP2 by the ubiquitin-like protein FAT10 inhibits its activity during cellular response to LPS.
Buchsbaum S, Bercovich B, Ziv T, Ciechanover A.
Biochem Biophys Res Commun 428(1):11-6. doi: 10.1016/j.bbrc.2012.09.110. Epub 2012 Oct 1. 2012
18TNF, UBD
FAT10 mediates the effect of TNF-α in inducing chromosomal instability.
Ren J, Wang Y, Gao Y, Mehta SB, Lee CG.
J Cell Sci 124(Pt 21):3665-75. Epub 2011 Oct 24. 2011
19UBD
FAT10 protein binds to polyglutamine proteins and modulates their solubility.
Nagashima Y, Kowa H, Tsuji S, Iwata A.
J Biol Chem 286(34):29594-600. Epub 2011 Jul 8. 2011
20UBD
FAT10 modifies p53 and upregulates its transcriptional activity.
Li T, Santockyte R, Yu S, Shen RF, Tekle E, Lee CG, Yang DC, Chock PB.
Arch Biochem Biophys 509(2):164-9. Epub 2011 Mar 9. 2011
21UBD
The ubiquitin-like protein FAT10 mediates NF-kappaB activation.
Gong P, Canaan A, Wang B, Leventhal J, Snyder A, Nair V, Cohen CD, Kretzler M, D'Agati V, Weissman S, Ross MJ.
J Am Soc Nephrol 21(2):316-26. Epub 2009 Dec 3. 2010
22UBD, USE1
USE1 is a bispecific conjugating enzyme for ubiquitin and FAT10, which FAT10ylates itself in cis.
Aichem A, Pelzer C, Lukasiak S, Kalveram B, Sheppard PW, Rani N, Schmidtke G, Groettrup M.
Nat Commun 1:13. doi: 10.1038/ncomms1012. 2010
23NUB1, UBD
Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L.
Schmidtke G, Kalveram B, Groettrup M.
FEBS Lett 583(3):591-4. Epub 2009 Jan 21. 2009
24UBD
FAT10 level in human gastric cancer and its relation with mutant p53 level, lymph node metastasis and TNM staging.
Ji F, Jin X, Jiao CH, Xu QW, Wang ZW, Chen YL.
World J Gastroenterol 15(18):2228-33. 2009
25HDAC6, UBD
The ubiquitin-like modifier FAT10 interacts with HDAC6 and localizes to aggresomes under proteasome inhibition.
Kalveram B, Schmidtke G, Groettrup M.
J Cell Sci 121(Pt 24):4079-88. Epub 2008 Nov 25. 2008
26UBD
Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon.
Lukasiak S, Schiller C, Oehlschlaeger P, Schmidtke G, Krause P, Legler DF, Autschbach F, Schirmacher P, Breuhahn K, Groettrup M.
Oncogene 27(46):6068-74. Epub 2008 Jun 23. 2008
27UBD
Role of ubiquitin-like protein FAT10 in epithelial apoptosis in renal disease.
Ross MJ, Wosnitzer MS, Ross MD, Granelli B, Gusella GL, Husain M, Kaufman L, Vasievich M, D'Agati VD, Wilson PD, Klotman ME, Klotman PE.
J Am Soc Nephrol 17(4):996-1004. Epub 2006 Feb 22. 2006
28UBD
FAT10 plays a role in the regulation of chromosomal stability.
Ren J, Kan A, Leong SH, Ooi LL, Jeang KT, Chong SS, Kon OL, Lee CG.
J Biol Chem 281(16):11413-21. Epub 2006 Feb 22. 2006
29NUB1, UBD
The UBA domains of NUB1L are required for binding but not for accelerated degradation of the ubiquitin-like modifier FAT10.
Schmidtke G, Kalveram B, Weber E, Bochtler P, Lukasiak S, Hipp MS, Groettrup M.
J Biol Chem 281(29):20045-54. Epub 2006 May 17. 2006
30UBD
FAT10, a ubiquitin-independent signal for proteasomal degradation.
Hipp MS, Kalveram B, Raasi S, Groettrup M, Schmidtke G.
Mol Cell Biol 25(9):3483-91. 2005
31UBD
Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers.
Lee CG, Ren J, Cheong IS, Ban KH, Ooi LL, Yong Tan S, Kan A, Nuchprayoon I, Jin R, Lee KH, Choti M, Lee LA.
Oncogene 22(17):2592-603. 2003
32UBD, MAD2L1
A MHC-encoded ubiquitin-like protein (FAT10) binds noncovalently to the spindle assembly checkpoint protein MAD2.
Liu YC, et al.
Proc Natl Acad Sci U S A 96(8):4313-8. 1999
33UBD
Identification and analysis of a novel member of the ubiquitin family expressed in dendritic cells and mature B cells.
Bates EE, Ravel O, Dieu MC, Ho S, Guret C, Bridon JM, Ait-Yahia S, Briere F, Caux C, Banchereau J, Lebecque S.
Eur J Immunol 27(10):2471-7. 1997
34BSN, GNL1, HFEC@, MOG, QMR1, RAN, TRAM2, TRIM15, TRIM27, TRNAS2, TRNAS3, TUBB, UBD
A transcription map of the major histocompatibility complex (MHC) class I region.
Gruen JR, Nalabolu SR, Chu TW, Bowlus C, Fan WF, Goei VL, Wei H, Sivakamasundari R, Liu Y, Xu HX, Parimoo S, Nallur G, Ajioka R, Shukla H, Bray-Ward P, Pan J, Weissman SM.
Genomics 36(1):70-85. 1996